Klaus Breiner - Profile and Investment Details

Investor Profile

Klaus Breiner is a Venture Capital, Private Equity Firm based in Freienbach, Schwyz, Switzerland with a diverse investment portfolio that includes companies such as Alpex Pharma SA, AM Pharma, AM-Pharma, Vico Therapeutics, NovaGo Therapeutics, Corlieve Therapeutics, Pevion Biotech AG, Pureos Partners AG, Alentis Therapeutics, Orthocon, Eyevensys, VICO Therapeutics B.V., Glycart Biotechnology AG, Araris Biotech, Lava Therapeutics, . Over time, Klaus Breiner has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Klaus Breiner is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Rare Diseases, Life Science, Engineering, Biotechnology, Drug Development, Precision Medicine, Clinical Trials, Research, Gene Therapy, Personalized Medicine, Medical, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Klaus Breiner, as their portfolio suggests a familiarity and interest in this area.

Understanding Klaus Breiner’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.